Earnings Call · Q3 FY2022·2022-11-02

Q3 22EPS +8.04%·Rev n/aQ2 22EPS +10.09%·Rev n/aQ1 22EPS +3.26%·Rev n/aQ4 21EPS +5.32%·Rev n/a⚠ consensus missing

CVS HEALTH Corp CVS

Larry McGrath — Senior Vice President of Business Development and Investor Relations

Karen Lynch — President and Chief Executive Officer

Shawn Guertin — Executive Vice President and Chief Financial Officer

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CVS calls or request research access.

More CVS calls Browse calls Request research access